Overbrook Management Corp Sells 3,867 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Overbrook Management Corp reduced its position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 5.3% during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 69,416 shares of the company's stock after selling 3,867 shares during the period. HealthEquity accounts for approximately 1.4% of Overbrook Management Corp's portfolio, making the stock its 27th largest holding. Overbrook Management Corp owned approximately 0.08% of HealthEquity worth $6,134,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Wealthfront Advisers LLC purchased a new stake in shares of HealthEquity during the 4th quarter valued at approximately $10,304,089,000. Vanguard Group Inc. lifted its stake in shares of HealthEquity by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company's stock valued at $861,256,000 after buying an additional 99,624 shares in the last quarter. FMR LLC lifted its holdings in HealthEquity by 2.4% during the 4th quarter. FMR LLC now owns 5,415,800 shares of the company's stock worth $519,646,000 after purchasing an additional 125,684 shares in the last quarter. Geode Capital Management LLC lifted its holdings in HealthEquity by 0.5% during the 4th quarter. Geode Capital Management LLC now owns 2,089,398 shares of the company's stock worth $200,522,000 after purchasing an additional 10,421 shares in the last quarter. Finally, Brown Advisory Inc. lifted its holdings in HealthEquity by 12.0% during the 4th quarter. Brown Advisory Inc. now owns 2,086,026 shares of the company's stock worth $200,154,000 after purchasing an additional 224,016 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Price Performance

Shares of NASDAQ:HQY traded up $0.02 on Friday, hitting $104.88. The company's stock had a trading volume of 958,705 shares, compared to its average volume of 857,323. The company has a 50-day simple moving average of $98.01 and a 200 day simple moving average of $98.00. HealthEquity, Inc. has a 1 year low of $65.01 and a 1 year high of $116.65. The company has a market capitalization of $9.07 billion, a PE ratio of 76.55, a PEG ratio of 1.61 and a beta of 0.49. The company has a debt-to-equity ratio of 0.50, a current ratio of 4.06 and a quick ratio of 4.06.

HealthEquity (NASDAQ:HQY - Get Free Report) last released its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.81 by $0.16. The firm had revenue of $330.80 million for the quarter, compared to analysts' expectations of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. During the same quarter last year, the firm posted $0.80 EPS. Sell-side analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

Insider Activity at HealthEquity

In related news, Director Jon Kessler sold 134,183 shares of the firm's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the transaction, the director now directly owns 253,510 shares in the company, valued at $28,413,400.80. This trade represents a 34.61% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the transaction, the director now owns 84,969 shares in the company, valued at approximately $6,597,842.85. The trade was a 6.34% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 304,581 shares of company stock valued at $33,664,018. Corporate insiders own 1.50% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. Bank of America increased their price objective on HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. Deutsche Bank Aktiengesellschaft increased their price objective on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a report on Thursday, June 5th. The Goldman Sachs Group increased their price objective on HealthEquity from $94.00 to $104.00 and gave the stock a "neutral" rating in a report on Wednesday, June 4th. JMP Securities increased their price objective on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a report on Wednesday, June 4th. Finally, Barrington Research increased their price objective on HealthEquity from $112.00 to $125.00 and gave the stock an "outperform" rating in a report on Thursday, June 5th. One research analyst has rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy" and an average target price of $118.09.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.